Circulating macrophage inflammatory protein-1 β/IL-12p40 ratio predicts sofosbuvir-based treatment outcome in HCV- genotype 4 patients

CONCLUSION: Baseline MIP-1β/IL-12p40 ratio represents a non-invasive prognostic biomarker that would provide shorter treatment duration and minimizes the emergence of drug-resistant variants in HCV genotype 4-patients.PMID:34511496 | DOI:10.3233/HAB-211504
Source: Human Antibodies - Category: Biochemistry Authors: Source Type: research